Rchr
J-GLOBAL ID:200901096610009900   Update date: Feb. 01, 2024

Kagawa Yoshiyuki

カガワ ヨシユキ | Kagawa Yoshiyuki
Affiliation and department:
Other affiliations (1):
  • 静岡県立総合病院  臨床研究部   薬物動態研究リーダー
Homepage URL  (1): http://w3pharm.u-shizuoka-ken.ac.jp/rinyaku/
Research field  (1): Clinical pharmacy
Research keywords  (5): 物理系薬剤学 ,  認知症治療薬 ,  抗てんかん薬 ,  抗がん薬 ,  臨床薬物動態学
Research theme for competitive and other funds  (6):
  • 2020 - 2023 Multidimensional analysis of factors influencing the pharmacokinetics of the third-generation antiepileptic drugs
  • 2016 - 2019 Studies on the Development of Clinical Free Radical Imaging Systme
  • 2016 - 2019 Mechanisms underlying clinical drug-drug interactions of antiepileptic drugs
  • 2013 - 2016 Pharmacokinetic/pharmacodynamic investigation for BPSD in dementia patients receiving donepezil.
  • 2012 - 2015 Constructing a community medical service support system with foreign residents: developing an educational program for medical interpreters.
Show all
Papers (157):
  • Tomonobu Uchino, Daichi Kamiya, Hiroaki Yagi, Hiyori Fujino-Shimaya, Ichiro Hatta, Shun Fujimori, Yasunori Miyazaki, Yukako Kirishita, Yuko Sano, Hajime Mizuno, et al. Comparative analysis of intercellular lipid organization and composition between psoriatic and healthy stratum corneum. Chemistry and physics of lipids. 2023. 254. 105305-105305
  • Tomonori Tayama, Masatake Ishiuchi, Kenichiro Sugiyama, Yuichi Oka, Hiroshi Maeda, Yoshinori Nagata, Matthew Hruska, Yoshiyuki Kagawa. Safety, Tolerability, and Pharmacokinetics of the Novel Adenosine A 2A Antagonist/Inverse Agonist KW-6356 Following Single and Multiple Oral Administration in Healthy Volunteers. Clinical Pharmacology in Drug Development. 2023
  • Asami Toshima, Yasuhisa Shiraishi, Daisuke Shinmi, Yoshiyuki Kagawa, Junichi Enokizono. Comprehensive analyses of the intracellular andin vivodisposition of Fab-siRNA conjugate to identify key issues to improve itsin vivoactivity. Drug Metabolism and Disposition. 2022. DMD-AR
  • Riko Asakawa, Youichi Ogawa, Eri Maejima, Akiko Honobe-Tabuchi, Takashi Okamoto, Hiroshi Mitsui, Yoshiyuki Kagawa, Shinji Shimada, Tatsuyoshi Kawamura. Case of bullous pemphigoid refractory to corticosteroids by antiepileptic drug-induced CYP3A4. The Journal of Dermatology. 2022
  • Yoshiaki Yamamoto, Yushi Inoue, Naotaka Usui, Katsumi Imai, Yoshiyuki Kagawa, Yukitoshi Takahashi. Therapeutic Drug Monitoring for Rufinamide in Japanese Patients With Epilepsy: Focus on Drug Interactions, Tolerability, and Clinical Effectiveness. Therapeutic drug monitoring. 2022. 44. 4. 585-591
more...
MISC (121):
more...
Education (3):
  • - 1995 博士(医学)三重大学
  • 1983 - 1985 静岡県立静岡薬科大学大学院薬学研究科博士前期課程
  • 1979 - 1983 静岡県立静岡薬科大学薬学部
Work history (7):
  • 2017/02 - 現在 浙江省医学科学院 客員教授
  • 2015/04 - 現在 静岡県立総合病院 臨床研究部 薬物動態研究リーダー(組織変更)
  • 2005/04 - 現在 University of Shizuoka School of Pharmaceutical Sciences
  • 2011/04 - 2015/03 静岡県立総合病院 薬物動態・安全性研究室 室長
  • 1996/04 - 2005/03 Mie University Hospital
Show all
Committee career (7):
  • 2022/04 - 現在 日本医療薬学会 教育委員会委員
  • 2018/04 - 2021/03 日本薬学会 薬学雑誌 編集長
  • 2017/04 - 2021/03 日本薬学会 BPB/CPB編集委員会 Section-Editor-In-Chief
  • 2017/04 - 2019/03 日本薬学会 理事
  • 2013/04 - 2017/03 日本薬学会 教育委員会委員
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page